Cargando…
Cisplatin remodels the tumor immune microenvironment via the transcription factor EB in ovarian cancer
The mortality rate of ovarian cancer (OC) remains the highest among all gynecological malignancies. Platinum-based chemotherapies are effective in treating most OC cases. However, chemoresistance is still a major challenge for successful OC treatments. Emerging evidence has highlighted that the modu...
Autores principales: | Liu, Wei, Wang, Yanqiu, Xie, Yunkai, Dai, Tianyu, Fan, Mingjun, Li, Changzhong, Zou, Yonghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179924/ https://www.ncbi.nlm.nih.gov/pubmed/34091590 http://dx.doi.org/10.1038/s41420-021-00519-8 |
Ejemplares similares
-
The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1
por: Dai, Tianyu, et al.
Publicado: (2021) -
Role of Transcription Factor EB in Mitochondrial Dysfunction of Cisplatin-Induced Acute Kidney Injury
por: Wang, Shujun, et al.
Publicado: (2023) -
The Transcription Factor EB Links Cellular Stress to the Immune Response
por: Nabar, Neel R., et al.
Publicado: (2017) -
Transcription factor EB regulates cardiovascular homeostasis
por: Lu, Haocheng, et al.
Publicado: (2021) -
Fournier’s Gangrene with Growth of Actinomyces europaeus: A Case Report
por: Zhang, Shurong, et al.
Publicado: (2023)